A Phase 2 Study of Triapine (NSC 663249) and Cisplatin in Combination With Pelvic Radiation for Treatment of Stage IB2-IVa Cervical Cancer or Stage II-IV Vaginal Cancer.

Trial Profile

A Phase 2 Study of Triapine (NSC 663249) and Cisplatin in Combination With Pelvic Radiation for Treatment of Stage IB2-IVa Cervical Cancer or Stage II-IV Vaginal Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Jun 2014

At a glance

  • Drugs Cisplatin (Primary) ; OCX 191 (Primary)
  • Indications Cervical cancer; Vulvovaginal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Jun 2012 Planned end date changed from 1 Mar 2012 to 1 Apr 2017 as reported by ClinicalTrials.gov.
    • 30 Nov 2011 Actual patient number is 26 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top